Immunogenicity of Recurrent Mutations in MYD88 and EZH2 in Non-Hodgkin Lymphomas
Journal for immunotherapy of cancer(2015)
摘要
Meeting abstracts A fundamental challenge in cancer genomics is to design effective, personalized treatments based on the mutational profiles of tumors. Pharmacological targeting of the numerous aberrant pathways found in individual tumors remains exceedingly challenging, but T cell-based therapies
更多查看译文
关键词
Lymphoma Patient,Peptide Library,Driver Mutation,Recurrent Mutation,Mutational Profile
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要